Brazil's Public Health System Expands Treatment Options for Atopic Dermatitis

Brazil's SUS Expands Atopic Dermatitis Treatment Options Brazil's public health system (SUS) has made a significant advancement in treating atopic dermatitis, a chronic skin condition. The SUS has incorporated three new medications: tacrolimus and fluocinolone acetonide ointments, and the oral medication methotrexate. These additions are particularly beneficial for patients who cannot tolerate corticosteroids, a common treatment for atopic dermatitis. "These ointments are for patients who can't use corticosteroids or have resistance to existing treatments," explains Dr. Juliana Nakano, a dermatologist featured in the video. She further emphasizes the chronic nature of the disease and its prevalence among children. The video shows images of atopic dermatitis lesions on various body parts, including the elbows, knees, and neck. Dr. Nakano also stressed the importance of daily hydration for managing the condition. She notes that severe cases may require oral or injectable therapies. "The treatment of atopic dermatitis has evolved significantly; there's no reason to give up on therapy," she says, offering hope to patients. This expansion of treatment options represents a positive step forward in providing accessible and effective care for atopic dermatitis sufferers in Brazil.